Association between microRNA polymorphisms and papillary thyroid cancer susceptibility

Area of Science:

• Genetics
• Oncology
• Molecular Biology

Background:

• Papillary thyroid cancer (PTC) is the most prevalent thyroid malignancy, with complex etiology involving genetic and environmental factors.
• MicroRNAs (miRNAs) are key regulators of gene expression, and their polymorphisms are implicated in cancer development.
• Previous studies suggest a link between miRNA gene polymorphisms and PTC susceptibility.

Purpose of the Study:

• To investigate the association between four common microRNA polymorphisms (miR-146a, miR-608, miR-933, and miR-149) and PTC risk in a Han Chinese population.
• To evaluate the diagnostic performance of miR-146a polymorphisms in PTC through a meta-analysis.

Main Methods:

• A case-control study involving 1,398 participants (369 PTC patients, 278 benign nodule patients, 751 controls).
• Genotyping of miRNA polymorphisms using MALDI-TOF mass spectrometry.
• Statistical analysis of odds ratios and 95% confidence intervals, supplemented by a meta-analysis.

Main Results:

• The miR-146a polymorphism was significantly associated with an elevated risk of PTC across various genetic models when compared to healthy and benign nodule controls.
• Meta-analysis results indicated no significant association between miR-146a polymorphisms and PTC risk.

Conclusions:

• The study suggests a potential association between miR-146a polymorphism and PTC risk in the studied population.
• Meta-analysis findings contradict this, highlighting the need for further research to clarify the role of miR-146a in PTC etiology.